The purpose of the current study was to retrospectively assess the effect of postoperative radiotherapy (RT) delay on survival for patients with esophageal cancer. From 2008 to 2011, patients with esophageal cancer who had undergone postoperative RT in five different hospitals in China were reviewed. Clinical data, including time interval between surgery to RT, were prospectively collected. Kaplan-Meier method was conducted to estimate the effect of each variable on progression-free survival (PFS) and overall survival (OS), with differences assessed by log-rank test. Univariate Cox proportional-hazards models were performed for both PFS and OS for all assumed predictor variables. Statistically significant predictor variables (P < .05) on univariate analysis were then included in multivariate Cox proportional-hazards models, which were performed to compare the effects of RT delay on PFS and OS. A total of 316 patients were finally enrolled in this prospectively multicentric study. Time to RT after surgery varied from 12 days to over 60 days (median, 26 days). Multivariate analysis showed that delay to RT longer than the median does not appear to be a survival cost. There was also no statistically difference in PFS (P = .513) or OS (P = .236) between patients stratified by quartiles (≤21 days vs ≧35 days). However, patients with particularly long delays (≧42 days) demonstrated a detrimental impact on OS (P = .021) but not PFS (P = .580). Delaying postoperative RT of esophageal cancer does not impact PFS, but results in a significant reduction on OS if delaying longer than 6 weeks.
Background: The resection of tumors in small breasts or in areas such as the upper and inner parts of the breast may have disabling cosmetic results. Tumor resection reduces the volume of the breast and may result in asymmetry or distortion of the nipple-areola complex. Autologous fat transfer/grafting has been shown to be a reliable technique for improving these poor cosmetic results. This study aimed to evaluate the feasibility, complications, and cosmetic outcomes of immediate autologous fat grafting during breast-conserving surgery (BCS) in Chinese patients with early-stage breast cancer. Methods: This retrospective study included 58 patients with early breast cancer treated by the same surgical team from October 2016 to May 2017. The patients were divided into two groups: BCS with lipofilling (experiment group, n=30) and BCS without lipofilling (control group, n=28). All patients received the recommended breast cancer treatment with complementary radiotherapy. The follow-up period after the completion of radiotherapy ranged from 36–44 months. The resected and grafted volumes, complications, esthetic results, patient satisfaction, and recurrence rate within 3 years were compared between the groups. Results: The average resected and grafted volumes in the lipofilled group were 47 and 74 mL, respectively, with only one seroma and no other complications. Regarding physician evaluation, BCS with lipofilling resulted in better cosmetic outcomes than BCS without lipofilling (33% versus 15%, respectively). Poor responses occurred in only 7% of patients with lipofilling, compared with 15% without lipofilling. Regarding patient self-evaluation, Breast-Q scores including patient satisfaction with their breasts and psychosocial well-being, were significantly higher in patients who received lipofilling compared with non-lipofilled patients. Regional recurrence occurred in one patient (case 21) (3.7%) in the lipofilling group and systemic recurrence occurred in one patient (case 12) (3.8%) in the control group. Conclusions: Immediate autologous fat grafting is a promising, effective, and convenient technique for partial breast reconstruction after BCS, with potentially higher levels of patient and physician satisfaction compared with traditional BCS. Trial Registration: Chinese Clinical Trial Registry ChiCTR-ONN-17010514. Registered 24 January 2017.
Purpose: Evidence implies that plasma fibrinogen and serum albumin level (FA score) based on plasma fibrinogen and serum albumin is related to cancer prognosis. However, the association between the FA score and therapeutic efficacy of concurrent radiochemotherapy in esophageal squamous cell carcinoma (ESCC) has not yet been evaluated. This study aimed to assess the role of pretreatment FA score in predicting the therapeutic efficacy of concurrent radiochemotherapy for patients with esophageal squamous cell cancer.Methods: This retrospective study evaluated 154 patients with ESCC who underwent concurrent radiochemotherapy. Receiver operating characteristic curve (ROC) analysis was used to determine the appropriate cut-off values, and multivariate analysis and Kaplan-Meier curve were used to evaluate prognosis.Results: FA score was significantly associated with the N stage and M stage (P = 0.015 and 0.042, respectively). Chi-square analysis/Fisher’s exact tests revealed a correlation between the FA score and curative effect (P < 0.001), and higher FA score was associated with poorer treatment effect. Multivariate analysis indicated that FA score (P < 0.001) was predictor of overall survival (OS). Kaplan-Meier curve demonstrated that pretreatment FA score was significantly associated with the OS of ESCC: Patient with higher FA score has lower median OS.Conclusions: The FA score is a reliable prognostic predictor that could assess the curative effect and OS benefit of concurrent radiochemotherapy in patients with ESCC.
Since the emergence of intelligent control, it has continuously developed and been applied to various fields, which has also greatly promoted the progress of clinical medicine and solved some difficult problems in clinical work. The development of intelligent control pushes the emergence and development of new technologies and new industries. It promotes a new wave of information technology, which continuously penetrates medicine. Intelligent control plays an increasingly important role, and its application in medical field is an inevitable trend. This article mainly gives examples of intelligent control in some clinical departments.
Objectives: To evaluate the cardioprotective effect of atorvastatin (Ator) via modulation of mitochondrial permeability transition pore (mPTP) through mitochondrial ATP-sensitive potassium channels (mitoKATP channels). Methods: Sprague-Dawley rat hearts were Langendorff-perfused with Krebs-Henseleit (K-H) buffer and subjected to 30 min global ischaemia followed by 120 min of reperfusion. In this study, the mitoKATP channels inhibitor 5-hydroxydecanoate (5-HD) and the mPTP opener lonidamine (LND) were used to analyse the underlying mechanisms. Rats were randomly divided into 7 groups: (1) control group; (2) ischaemia/reperfusion (I/R) group; (3) Ator group; (4) Ator + 5-HD group; (5)Ator + LND group; (6) 5-HD group; (7) LND group. The parameters of cardiac function, myocardial infarct size, lactate dehydrogenase (LDH) in the coronary effluent and ATP content in myocardium were measured. To investigate the relationship between mitoKATP channels and mPTP implicated in Ator preconditioning, NAD+ content, a marker of mPTP opening, was measured. Results: Compared with the I/R group, Ator (1 μM) preconditioning significantly improved cardiac functional recovery, decreased myocardial infarct size, reduced LDH release, prevented ATP and NAD+ depletion (P < 0.05 vs. I/R group). However, these protective effects of Ator were abolished in the presence of either 5-HD (100 μM) or LND (30 μM). Conclusions: Ator may protect myocardium in response to I/R injury by inhibiting the mPTP opening through activating the mitoKATP channels. Moreover, the mitoKATP channels may be upstream of the mPTP.